{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-354092","form_type":"8-K","ticker":"MAZE","cik":"0001842295","company_name":"Maze Therapeutics, Inc.","filed_at":"2026-08-17T20:16:30+00:00","discovered_at":"2026-08-17T20:17:01.297544+00:00","generated_at":"2026-08-17T20:17:27.889972+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Maze Therapeutics appoints Paula Johnson and Sophie Kornowski to board; pipeline milestones ahead","bullets":["Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., appointed to Maze's board effective Aug 13, 2026.","Johnson is President of Wellesley College and J&J board member; Kornowski ex-CEO of Boston Pharmaceuticals, led GSK acquisition.","Board class changes: Nancy Andrews moved to Class II, Hervé Hoppenot to Class III to balance classes.","CEO Jason Coloma cites upcoming data: MZE829 in AMKD late 2026/early 2027, MZE782 initial data in 2027.","Each new director receives pro-rata $40k cash retainer and option for 36,000 shares vesting monthly over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-354092","json":"https://secwatch.observer/filing/0001193125-26-354092.json","markdown":"https://secwatch.observer/filing/0001193125-26-354092.md","text":"https://secwatch.observer/filing/0001193125-26-354092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842295/000119312526354092/0001193125-26-354092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842295/000119312526354092/d135740d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T20:17:27.889972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}